HEALTH CATALYST INC

NASDAQ: HCAT (Health Catalyst, Inc)

Last update: 19 Sep, 3:38PM

8.83

0.09 (1.03%)

Previous Close 8.74
Open 9.00
Volume 445,610
Avg. Volume (3M) 533,777
Market Cap 533,951,872
Price / Earnings (Forward) 21.14
Price / Sales 1.58
Price / Book 1.38
52 Weeks Range
5.42 (-38%) — 11.41 (29%)
Earnings Date 31 Oct 2024 - 4 Nov 2024
Profit Margin -28.87%
Operating Margin (TTM) -15.94%
Diluted EPS (TTM) -1.49
Quarterly Revenue Growth (YOY) 3.70%
Total Debt/Equity (MRQ) 69.66%
Current Ratio (MRQ) 1.18
Operating Cash Flow (TTM) -4.05 M
Levered Free Cash Flow (TTM) 27.76 M
Return on Assets (TTM) -6.58%
Return on Equity (TTM) -23.15%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Mixed Bearish
Health Information Services (Global) Mixed Bearish
Stock Health Catalyst, Inc Bullish Bullish

Stockmoo Score

1.8
Analyst Consensus 1.5
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 2.5
Technical Oscillators 5.0
Average 1.75

Similar Stocks

Stock Market Cap DY P/E P/B
HCAT 534 M - - 1.38
BTSG 3 B - - 1.74
PINC 2 B 4.12% 19.59 1.06
SHCR 528 M - - 1.37
DH 477 M - - 0.820
SPOK 309 M 6.14% 18.40 1.89

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Sector Healthcare
Industry Health Information Services
Investment Style Small Value
% Held by Insiders 2.82%
% Held by Institutions 89.42%

Ownership

Name Date Shares Held
Daventry Group, Lp 30 Jun 2024 2,247,053
Nepsis Inc. 30 Jun 2024 1,253,080
52 Weeks Range
5.42 (-38%) — 11.41 (29%)
Price Target Range
7.00 (-20%) — 16.00 (81%)
High 16.00 (Cantor Fitzgerald, 81.20%) Buy
Median 11.00 (24.58%)
Low 7.00 (Stephens & Co., -20.73%) Hold
Average 11.40 (29.11%)
Total 4 Buy, 1 Hold
Avg. Price @ Call 7.56
Firm Date Target Price Call Price @ Call
Evercore ISI Group 08 Oct 2024 10.00 (13.25%) Buy 7.83
Cantor Fitzgerald 04 Oct 2024 16.00 (81.20%) Buy 7.70
20 Sep 2024 16.00 (81.20%) Buy 8.69
JP Morgan 04 Sep 2024 13.00 (47.23%) Buy 7.54
Piper Sandler 26 Aug 2024 11.00 (24.58%) Buy 7.16
Stephens & Co. 08 Aug 2024 7.00 (-20.72%) Hold 7.55

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria